A transcriptomic signature to predict adjuvant gemcitabine sensitivity in pancreatic adenocarcinoma
{{output}}
Background: Chemotherapy is the only systemic treatment approved for pancreatic ductal adenocarcinoma (PDAC), with a selection of regimens based on patients' performance status and expected efficacy. The establishment of a potent... ...
